"10.1371_journal.pone.0094858","plos one","2014-04-10T00:00:00Z","Hila Haskelberg; Nicholas Pocock; Janaki Amin; Peter Robert Ebeling; Sean Emery; Andrew Carr; STEAL study investigators","The Kirby Institute, University of New South Wales, Sydney, Australia; St. Vincent's Hospital, Sydney, Australia; North West Academic Centre, University of Melbourne, Melbourne, Australia","Conceived and designed the experiments: HH, NP, AC. Performed the experiments: HH, NP. Analyzed the data: HH. Contributed reagents/materials/analysis tools: NP. Wrote the paper: HH. All authors reviewed all data and analyses, and reviewed the manuscript.","The authors have read the journal's policy and have the following conflicts: Sean Emery is a PLOS ONE Editorial Board member. Hila Haskelberg and Janaki Amin declare no conflict of interest. Nicolas Pocock received consultancy fees from Merck, Sanofi Aventis and Servier; and has served on an advisory board for Merck. Peter Ebeling's institution has received research funding from Merck; consultancy fees from Gilead Sciences and GlaxoSmithKline/ViiV Healthcare; and has served on an advisory board for Merck. Sean Emery has received research grant support from Abbvie, Gilead Sciences, Merck Research Laboratories, Pfizer, and ViiV Healthcare. Andrew Carr has received research funding from ViiV Healthcare, and Merck; consultancy fees from Gilead Sciences, ViiV Healthcare, MSD and Roche; lecture and travel sponsorships from Gilead Sciences, MSD, and ViiV Healthcare; and has served on advisory boards for Gilead Sciences, MSD, and ViiV Healthcare. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.","2014","04","Hila Haskelberg","HH",7,TRUE,3,2,1,1,TRUE,TRUE,TRUE,4,"3;4;5;7",TRUE
